Evidence map›Paper›PMID 11356858›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2001

Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.

M Narita, H Mizoguchi, M Narita, H Nagase, T Suzuki, L F Tseng

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Antinociceptive Activity of Methanolic Extract ofPain research & management · 2018
    Article
  3. Article
  4. Article
  5. Pain after discontinuation of morphine treatment is associated with synaptic increase of GluA4-containing AMPAR in the dorsal horn of the spinal cord.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2013
    Article
  6. Article
  7. Article
  8. Involvement of NOX1/NADPH oxidase in morphine-induced analgesia and tolerance.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  9. Change in microRNAs associated with neuronal adaptive responses in the nucleus accumbens under neuropathic pain.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  10. Article
  11. Article
  12. Opioids: a review.Current pain and headache reports · 2003
    Review
  13. Article
  14. Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2002
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

M NaritaDepartment of Toxicology, Hoshi University, School of Pharmacy, Tokyo, 142-8501, Japan.
H Mizoguchi
M Narita
H Nagase
T Suzuki
L F Tseng
Medical College of Wisconsin · USHoshi University · JP

Funding

SPINAL RELEASE OF ENDORPHINS BY OPIOIDSR01DA003811 · NIDA · MEDICAL COLLEGE OF WISCONSIN · PI TSENG, LEON FU · 1985 to 2002
$639k
NIDA NIH HHS DA 03811
6 · The paper itself

Abstract

The present study was designed to investigate the role of a protein kinase C (PKC) isoform in the uncoupling of the mu-opioid receptor from G-proteins after repeated intrathecal injection of a selective mu-receptor agonist, [D-Ala(2),N-MePhe(4),Gly-ol(5)]enkephalin (DAMGO), in the spinal cord of mice. The activation of G-proteins by opioids was measured by monitoring the guanosine-5'-o-(3-[(35)S]thio)triphosphate ([(35)S]GTPgammaS) binding. Mice were injected intrathecally with saline or DAMGO once a day for 1-7 d. At 24 hr after every injection the spinal cord membranes were prepared for the assay. The enhanced [(35)S]GTPgammaS binding by mu-agonists DAMGO, endomorphin-1, or endomorphin-2 was attenuated clearly in spinal cord membranes obtained from mice that were treated intrathecally with DAMGO for 5 and 7 d, but not for 1 or 3 d. By contrast, no change in levels of [(35)S]GTPgammaS binding induced by the delta-receptor agonist SNC-80 or kappa-receptor agonist U-50,488H was noted in membranes obtained from mice that were treated with DAMGO. Concomitant intrathecal administration of a specific PKC inhibitor Ro-32-0432 with DAMGO blocked the attenuation of DAMGO-induced G-protein activation that was caused by chronic DAMGO treatment. Western blotting analysis showed that chronic DAMGO treatment increased the levels of PKCgamma, but not PKCalpha, PKCbetaI, and PKCbetaII isoforms, in spinal cord membranes. Furthermore, mice lacking PKCgamma failed to exhibit the desensitization of the DAMGO-stimulated [(35)S]GTPgammaS binding after repeated DAMGO injection. These findings indicate that repeated intrathecal administration of DAMGO may activate the PKCgamma isoform and in turn cause a desensitization of mu-receptor-mediated G-protein activation in the mouse spinal cord.

Indexed as

AnimalsBinding, CompetitiveCell MembraneDrug Administration ScheduleEnkephalin, Ala(2)-MePhe(4)-Gly(5)-Enzyme InhibitorsGTP-Binding ProteinsGuanosine 5'-O-(3-Thiotriphosphate)Injections, SpinalIsoenzymesMaleMiceMice, KnockoutOligopeptidesProtein Kinase CReceptors, Opioid, deltaendomorphin 1endomorphin 2Enkephalin, Ala(2)-MePhe(4)-Gly(5)-Enzyme InhibitorsGTP-Binding ProteinsGuanosine 5'-O-(3-Thiotriphosphate)IsoenzymesOligopeptidesProtein Kinase Cprotein kinase C gammaReceptors, Opioid, deltaReceptors, Opioid, kappaReceptors, Opioid, mu

Identifiers

PMID11356858
PMCPMC6762716
OpenAlexW1896872049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.